BioPorto A/S (CPH:BIOPOR)
Denmark flag Denmark · Delayed Price · Currency is DKK
1.120
0.00 (0.00%)
Sep 25, 2026, 4:59 PM CET

BioPorto Revenue

BioPorto had revenue of 6.90M DKK in the quarter ending June 30, 2026, a decrease of -34.83%. This brings the company's revenue in the last twelve months to 38.37M, up 7.06% year-over-year. In the year 2025, BioPorto had annual revenue of 40.29M with 11.16% growth.

Revenue (ttm)
38.37M
Revenue Growth
+7.06%
P/S Ratio
14.45
Revenue / Employee
872.02K
Employees
44
Market Cap
554.52M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202540.29M4.04M11.16%
Dec 31, 202436.24M5.29M17.07%
Dec 31, 202330.96M1.99M6.87%
Dec 31, 202228.97M4.72M19.44%
Dec 31, 202124.25M1.05M4.53%
Dec 31, 202023.20M-3.42M-12.84%
Dec 31, 201926.62M606.00K2.33%
Dec 31, 201826.02M861.00K3.42%
Dec 31, 201725.16M4.44M21.40%
Dec 31, 201620.72M337.00K1.65%
Dec 31, 201520.38M1.68M8.97%
Dec 31, 201418.71M2.08M12.51%
Dec 31, 201316.63M-1.23M-6.90%
Dec 31, 201217.86M-726.00K-3.91%
Dec 31, 201118.58M4.78M34.65%
Dec 31, 201013.80M2.79M25.38%
Dec 31, 200911.01M1.13M11.47%
Dec 31, 20089.88M1.54M18.41%
Dec 31, 20078.34M2.79M50.16%
Dec 31, 20065.55M1.19M27.33%
Dec 31, 20054.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Novo Nordisk329.43B
Coloplast28.44B
Genmab27.03B
Demant24.63B
ChemoMetec511.06M
Gubra271.02M
Scandinavian Medical Solutions214.99M
Stenocare11.52M
Revenue Rankings